Medical Equipment - New York, NY, US
Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health. We've engineered a proprietary solution that successfully enables early-stage, progression risk assessment when it counts the most. Renalytix. Right here, until kidney disease isn't.™
Outlook
WP Engine
Typekit
Microsoft Office 365
Google Cloud Hosting
Adobe Marketing Cloud